Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 19 Neoplasms 7 Osteosarcoma 5 Gastrointestinal Stromal Tumors 4 Neuroblastoma 3 Melanoma 3 Uterine Cervical Neoplasms 2 Testicular Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Lung Neoplasms 2 Glioma 2 Esophageal Neoplasms 2 Desmoid Tumors 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Somatostatinoma 1 Skin Neoplasms 1 Sarcoma, Myeloid 1 Sarcoma, Ewing 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplastic Cells, Circulating 1

Interventions

Doxorubicin 18 Ifosfamide 13 Radiotherapy 8 Paclitaxel 7 pazopanib 6 pembrolizumab 4 Gemcitabine 4 Filgrastim 4 Chemotherapy, Adjuvant 4 Bevacizumab 4 spartalizumab 3 durvalumab 3 Sorafenib 3 Propranolol 3 Nivolumab 3 Ipilimumab 3 Imatinib Mesylate 3 Etoposide 3 Epirubicin 3 Docetaxel 3 Carboplatin 3 trebananib 2 regorafenib 2 cixutumumab 2 cemiplimab 2 carotuximab 2 brostallicin 2 belinostat 2 balstilimab 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hemangiosarcoma × Blood Specimen Collection × Sarcoma × Clear all

NCT01786889 2016-07-29

ANGIHE

Centre Oscar Lambret

Phase NA Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡